Lupin Limited has informed the Exchange regarding a press release dated February 17, 2022, titled "Lupin Announces FDA Approval of Supplemental New Drug Application forSOLOSEC�� (secnidazole) in Adolescents for both the Treatment of BacterialVaginosis in Females and Trichomoniasis.".